gimli
DRREDDY stock analysis context
DR. REDDY S LABORATORIES Stock Context for AI Screening
DR. REDDY S LABORATORIES is a large-cap stock in Healthcare. This page summarizes key screening signals for DR. REDDY S LABORATORIES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about DRREDDYPrice
₹1,307.20
1M return
+7.41%
3M return
+2.09%
Market cap
₹108,836.79 cr
PE
25.40
ROE
+13.88%
RSI
52.61
Turnover
₹261.76 cr
Why it can matter in screens
- Momentum: DRREDDY is above 50DMA, above 200DMA; RSI is 52.61.
- Returns: 1M +7.41%, 3M +2.09%, 6M +5.09%.
- Liquidity: latest turnover is ₹261.76 cr.
- Valuation: PE 25.40, PB 2.86, ROE +13.88%, ROCE +17.11%.
- Growth: 3Y sales CAGR +14.93%, 3Y profit CAGR +33.86%.
Try these prompts
- Analyze DR. REDDY S LABORATORIES with valuation, momentum and industry peers
- Compare DRREDDY with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare DRREDDY with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.